REG - Venture Life Group - Exercise of Share Options & Total Voting Rights

Venture LifeAnnouncement

21/01/2025 08:30

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250121:nRSU1117Ua&default-theme=true

RNS Number : 1117U  Venture Life Group PLC  21 January 2025

21 January 2025

 

VENTURE LIFE GROUP PLC

("Venture Life", "VLG" or the "Group")

Exercise of Share Options & Total Voting Rights

 

Venture Life Group PLC (AIM: VLG), a leader in developing, manufacturing and
commercialising products for the international self-care market, announces
that it has issued 1,000,000 ordinary shares of 0.3 pence each in the capital
of the Company ("Ordinary Shares") in accordance with an exercise of share
options, subject to admission to trading on AIM.

Application will be made to the London Stock Exchange for the 1,000,000 new
Ordinary Shares to be admitted to trading on AIM ("Admission") and it is
expected that Admission will become effective, and trading will commence at
8.00 a.m. on 24 January 2025.

Following Admission, the total number of Ordinary Shares in issue will be
128,052,312 and the total number of voting rights will therefore be
128,052,312. This figure may be used by shareholders as the denominator for
the calculations by which they will determine if they are required to notify
their interest in, or a change to their interest in, the share capital of the
Company under the FCA's Disclosure and Transparency Rules.

 

For further information, please contact:

Venture Life Group PLC
                                            +44 (0)
1344 578004

Jerry Randall, Chief Executive Officer

Daniel Wells, Chief Financial Officer

 

Cavendish Capital Markets Limited (Nomad and Broker)
                         +44 (0) 20 7720 0500

Stephen Keys/Camilla Hume (Corporate Finance)

Michael Johnson (Sales)

 

About Venture Life (www.venture-life.com (https://www.venture-life.com/) )

Venture Life is an international consumer self-care company focused on
developing, manufacturing and commercialising products for the global
self-care market. With operations in the UK, Italy, The Netherlands and
Sweden, the Group's product portfolio includes some key products such as the
UltraDEX and Dentyl oral care product ranges, the Balance Activ range in the
area of women's intimate healthcare, the Lift and Glucogel product ranges for
hypoglycaemia, Gelclair and Pomi-T for oncology support, Earol for ear wax
removal, products for fungal infections and proctology, and dermo-cosmetics
for addressing the signs of ageing. Its products are sold in over 90 countries
worldwide.

The products, which are typically recommended by pharmacists or healthcare
practitioners, are available primarily through pharmacies and grocery
multiples. In the UK and The Netherlands these are supplied direct by the
company to retailers, elsewhere they are supplied by the Group's international
distribution partners.

Through its two Development & Manufacturing operations in Italy and
Sweden, the Group also provides development and manufacturing services to
companies in the medical devices and cosmetic sectors.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  IOEVFLBLEFLFBBL